(Q34889352)

English

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

0 references

1 reference

based on heuristic

inferred from title

0 references

object named as

Tony W Ho

1

0 references

3

object named as

David W Dodick

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

2

object named as

Michel D Ferrari

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Vince Galet

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

James Kost

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Xiaoyin Fan

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Heather Leibensperger

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Samar Froman

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Christopher Assaid

9

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Christopher Lines

10

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Hille Koppen

11

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Paul K Winner

12

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

25 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

372

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

9656

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

2115-2123

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

The global burden of headache: a documentation of headache prevalence and disability worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Triptan nonresponder studies: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of use of triptans and reasons for switching them in a tertiary care migraine population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcitonin gene-related peptide (CGRP) and migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

CGRP may play a causative role in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

New therapeutic target in primary headaches - blocking theCGRP receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-relate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for controlled trials of drugs in migraine: second edition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of a New Quality of Life Questionnaire for Acute Migraine Headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

On closed testing procedures with special reference to ordered analysis of variance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of Rizatriptan 10 mg administered early in a migraine attack

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961626-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(08)61626-8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34889352&oldid=1605780935"